- Pfizer’s bivalent COVID-19 vaccine has been approved for use in Australia.
- ATAGI noted an extra booster was unlikely to reduce the fourth wave of cases.
- It will be available from 12 December for people aged 18 and older.
“Any reduction in transmission by adding a fifth dose to the system would, in (ATAGI’s) words, likely be minimal.”
“It’s not driven by any particular sub-variant of the Omicron strain of the virus – it’s been something of a soup of other variants,” he said.
Sharp increase in COVID-19 cases
While cases are rising, Mr Butler said the case numbers were about 85 per cent below the numbers seen during the peak in late July.
ATAGI has also approved the paediatric Pfizer vaccine for at-risk children between six months old and five years old, with the rollout to begin mid-January.
“All of the tools in the armoury that we would want to deal with a wave are well supplied, unlike last summer,” he said.